Fungemia clinical trials
The registry lists 32 studies for Fungemia across more than 10 countries. 3 are recruiting or about to start. 10 of them are mainly about Fungemia (how this is decided). Per ClinicalTrials.gov, last updated 2026-10-30. Counting its narrower condition Candidemia too: 97 studies, 7 open.
Get an email when these change. Save the Fungemia studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Who runs them
National Cancer Institute (NCI) (5) · Pfizer (2) · University of Pittsburgh (2) · Cidara Therapeutics Inc. (2) · Mayo Clinic (1) · University Hospital, Grenoble (1) · Hunter Holmes Mcguire Veteran Affairs Medical Center (1) · Daniel Benjamin (1)
What is being tested here
Drugs under test in Fungemia studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted
| Drug | Open | Phase 3 | All |
|---|---|---|---|
| Rezafungin | 0 | 2 | 3 |
| Micafungin | 0 | 2 | 3 |
| Voriconazole | 0 | 2 | 3 |
| Fluconazole | 0 | 1 | 2 |
| Anidulafungin | 0 | 0 | 1 |
| Omiganan pentahydrochloride | 0 | 1 | 1 |
| Caspofungin | 0 | 0 | 1 |
Coming up
Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.
All 2
- Dec 2026Clinical Efectiveness of a Multiplex PCR-Based Rapid Diagnostic Method in Bloodstream Infections · Istanbul Medipol University Hospital
- Apr 2027Evaluation of Diagnostic Accuracy and Clinical Performance of the UllCORE Bloodstream Infection (BSI) Test · Deepull Diagnostics S.L.
Who these studies take
Of the 3 Fungemia studies recruiting now, 3 (100%) set no upper age limit and 0 (0%) stop at 75 or younger. 1 (33%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 0 (0%) take healthy volunteers.
| Age | Women | Men |
|---|---|---|
| 10 | 1 (33%) | 1 (33%) |
| 18 | 3 (100%) | 3 (100%) |
| 30 | 3 (100%) | 3 (100%) |
| 40 | 3 (100%) | 3 (100%) |
| 50 | 3 (100%) | 3 (100%) |
| 65 | 3 (100%) | 3 (100%) |
| 75 | 3 (100%) | 3 (100%) |
| 85 | 3 (100%) | 3 (100%) |
Across all 32 studies, recruiting or not: 9% stop at 75 or younger and 3% at 65; 50% take children; 0% are for women only and 0% for men only; 0% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.
What changed recently
From the registry's own updates since Oct 12, 2026.
Newly registered1
- Middle East Study of Infections in Patients With Hematological MalignanciesOct 28, 2026NCT07900542
Studies
Recruiting first, then most recently updated. Showing 32 of 32. search them.
- Middle East Study of Infections in Patients With Hematological MalignanciesRecruitingNCT079005425 countries
- Evaluation of Diagnostic Accuracy and Clinical Performance of the UllCORE Bloodstream Infection (BSI) TestRecruitingNCT078598525 countries
- Clinical Efectiveness of a Multiplex PCR-Based Rapid Diagnostic Method in Bloodstream InfectionsRecruitingNCT074085441 country
- Metagenomic Sequencing for the Identification of Pathogens in Febrile Neutropenic PatientsTerminatedNCT06075888Not applicable1 country
- Study of Rezafungin Compared to Standard Antimicrobial Regimen for Prevention of Invasive Fungal Diseases in Adults Undergoing Allogeneic Blood and Marrow TransplantationCompletedNCT04368559Phase 39 countries
- Study of Rezafungin Compared to Caspofungin in Subjects With Candidemia and/or Invasive CandidiasisCompletedNCT03667690Phase 318 countries
- Clinical and Medico-economic Evaluation of a Rapid Test (ePlex-BCID®, GenMark) for the Diagnosis of Bacteremia and Fungemia.CompletedNCT03876990Not applicable1 country
- Clinical Evaluation of Novel Biomarkers in Patients With SepticemiaCompletedNCT013598911 country
- CD101 Compared to Caspofungin Followed by Oral Step Down in Subjects With Candidemia and/or Invasive Candidiasis-Bridging ExtensionCompletedNCT02734862Phase 210 countries
- Retrospective Chart Review of Candida FungemiaCompletedNCT038273301 country
- Impact of Rapid Pathogen Identification From Blood Cultures (RABbIT)Status unknownNCT02743585Not applicable1 country
- Pharmacokinetics (PK) Study of a Fluconazole Loading Dose in Infants and ToddlersCompletedNCT00797420Phase 11 country
- Clinical Performance of the Accelerate ID/AST System for Positive Blood CultureCompletedNCT027197691 country
- Fungemia in Hematologic MalignanciesCompletedNCT024515921 country
- Evaluation in the Treatment of Nosocomial Sepsis Comparing Polymerase Chain Reaction With Conventional Blood Culture.CompletedNCT01450358Phase 41 country
- A Study to Compare Efficacy and Safety of Mycamine® and Itraconazole for Preventing Fungal InfectionsCompletedNCT00794703Phase 31 country
- Rapid Identification and Susceptibility Testing of Pathogens From Blood CulturesCompletedNCT01898208Not applicable1 country
- Anidulafungin Versus Fluconazole for the Prevention of Fungal Infections in Liver Transplant RecipientsCompletedNCT00841971Phase 41 country
- An Evaluation Of The Effectiveness And Safety Of Anidulafungin Compared To Caspofungin For The Treatment Of Deep Tissue Infection Due To CandidaTerminatedNCT00805740Phase 39 countries
- Prospective Population Study on Candidemia in SpainCompletedNCT012362611 country
- An Evaluation Of The Effectiveness And Safety Of Anidulafungin Compared To Caspofungin For The Treatment Of Serious Fungal Infection Due To Candida In Patients With A Dysfunctional Immune SystemTerminatedNCT00806351Phase 36 countries
- Voriconazole as Prophylaxis for Liver Transplant RecipientsCompletedNCT001777881 country
- Caspofungin as Prophylaxis in High Risk Liver Transplantation RecipientsStatus unknownNCT01260974Phase 21 country
- The Relationship Between Morphology and Virulent Genes of Candida Albicans and Clinical Aspects, Surveillance of FungemiaStatus unknownNCT012110411 country
- Voriconazole to Treat Fungal InfectionsCompletedNCT00001940Phase 31 country
- Comparing the Effectiveness of Fluconazole and a New Medicine (FK463) in Preventing Fungal Infections in Bone Marrow Transplant PatientsCompletedNCT00001937Phase 31 country
- Phase I Study of the Safety, Tolerance, and Pharmacokinetics of FK463 in Immunocompromised Children With Fever and NeutropeniaCompletedNCT00001790Phase 11 country
- Voriconazole to Prevent Systemic Fungal Infections in ChildrenCompletedNCT00005912Phase 11 country
- An Open Label, Non-Comparative, Multicenter, Phase III Trial of the Efficacy, Safety and Toleration of Voriconazole in the Primary or Secondary Treatment of Invasive Fungal InfectionsCompletedNCT00001810Phase 31 country
- Evaluate Three Methods for Diagnosis of Invasive Fungal Infection in Chinese Patients After HSCTStatus unknownNCT004603301 country
- The Impact of Chlorhexidine-Based Bathing on Nosocomial InfectionsCompletedNCT004489421 country
- Safety and Efficacy of MBI 226 for the Prevention of Central Venous Catheter-Related Bloodstream InfectionsCompletedNCT00027248Phase 31 country